# COMETRIQ
> **NDA203756** · New Drug Application · Sponsor: EXELIXIS · Approved 2012-11-29
## Drug
- **FDA Application Number:** NDA203756
- **Application type:** New Drug Application
- **Brand name:** COMETRIQ
- **Generic name:** CABOZANTINIB
- **Active ingredients:** CABOZANTINIB S-MALATE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** EXELIXIS
- **Manufacturer:** Exelixis, Inc.
- **First approval:** 2012-11-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203756)
---
*MORVS · CC0 1.0*